Claritev Corporation Reports Fourth Quarter 2025 Results
Claritev Corporation reports financial results for the fourth quarter ended December 31, 2025 highlighting growth.
-
-
Healthcare Turns to AI to Cut Administrative Costs and Unlock Faster Claims Decisions
Discover how Claritev’s Chief AI Officer, Fernando Schwartz, is leveraging advanced AI to reduce healthcare’s administrative burden—streamlining claims processing, accelerating decisions, and cutting costs in an industry where bureaucracy accounts for 15–25% of total expenses.
-
Detecting Infectious Disease Waste & Abuse
Claritev has identified more than $22 million in waste and abuse for clients through its proactive, data-driven approach to payment integrity. By closely analyzing infectious disease billing patterns—including rising trends in RSV and COVID‑19—Claritev helps organizations detect errors early, prevent overpayments, and strengthen protection against emerging sources of waste and abuse.
-
Harnessing Data and AI to Reimagine Healthcare Economics
Healthcare providers are facing mounting financial pressure driven by rising costs, complexity, and misaligned incentives. This blog explores how leveraging data and AI can bring greater transparency to pricing, uncover hidden opportunities, and enable smarter decisions that improve both financial performance and patient engagement.
-
Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call
Claritev will release its Q2 2025 financial results on August 6, at 8:00 AM ET. Gain valuable insights into our vision to drive affordability in healthcare. Pre-register now for access to the call.
-
eBook: Future of Payment Integrity
Payment integrity in healthcare is evolving faster than ever. Rising costs, complex regulations, and emerging technologies demand a fresh approach. Claritev's new eBook offers a comprehensive roadmap to help your organization navigate these challenges, leverage AI-driven solutions, and partner with experts who deliver measurable results.
-
White Paper: Understanding Surgical Costs for Plan Sponsors
In this white paper, Claritev’s comprehensive surgical cost analysis provides insights to help understand and optimize healthcare expenditure through a data-driven approach.
-
Managing GLP-1 Drug Expenses: Every Company’s Cost Profile is Unique
Struggling with managing rising GLP-1 drug costs? Every company's cost drivers are different, making a one-size-fits-all approach ineffective. Learn how data-driven insights can help employers balance coverage and costs while optimizing member outcomes.
-
Claritev and Law Enforcement Are On To These Healthcare Claim Schemes
As a part of Claritev’s Payment Integrity service, we review claims to ensure there are no billing errors and that the charges make sense. When we find mistakes or suspicious charges, we investigate. This blog details findings that left us shaking our heads.
-
DataFramed Podcast: Using Data to Optimize Costs in Healthcare
Listen to Claritev's CEO, Travis Dalton, and Vice President of Product Development, Data & Decision Science, Jocelyn Jiang, discuss using healthcare data to solve seemingly intractable problems.